Trevi Therapeutics Stock Forward View - Accumulation Distribution

TRVI Stock  USD 11.46  0.52  4.75%   
Trevi Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Trevi Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 8th of February 2026 the relative strength index (rsi) of Trevi Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Trevi Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Trevi Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Trevi Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.11)
EPS Estimate Current Year
(0.36)
EPS Estimate Next Year
(0.45)
Wall Street Target Price
21.5455
EPS Estimate Current Quarter
(0.10)
Using Trevi Therapeutics hype-based prediction, you can estimate the value of Trevi Therapeutics from the perspective of Trevi Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Trevi Therapeutics using Trevi Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Trevi using crowd psychology based on the activity and movement of Trevi Therapeutics' stock price.

Trevi Therapeutics Short Interest

A significant increase or decrease in Trevi Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Trevi. Short interest can provide insight into the potential direction of Trevi Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA
8.9564
Short Percent
0.1395
Short Ratio
10.28
Shares Short Prior Month
14.1 M
50 Day MA
11.9426

Trevi Relative Strength Index

Trevi Therapeutics Hype to Price Pattern

Investor biases related to Trevi Therapeutics' public news can be used to forecast risks associated with an investment in Trevi. The trend in average sentiment can be used to explain how an investor holding Trevi can time the market purely based on public headlines and social activities around Trevi Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Trevi Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Trevi Therapeutics.

Trevi Therapeutics Implied Volatility

    
  1.6  
Trevi Therapeutics' implied volatility exposes the market's sentiment of Trevi Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Trevi Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Trevi Therapeutics stock will not fluctuate a lot when Trevi Therapeutics' options are near their expiration.

Trevi Therapeutics after-hype prediction price

    
  USD 11.44  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Trevi Therapeutics to cross-verify your projections.
For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.

Prediction based on Rule 16 of the current Trevi contract

Based on the Rule 16, the options market is currently suggesting that Trevi Therapeutics will have an average daily up or down price movement of about 0.1% per day over the life of the 2026-04-17 option contract. With Trevi Therapeutics trading at USD 11.46, that is roughly USD 0.0115 . If you think that the market is fully incorporating Trevi Therapeutics' daily price movement you should consider acquiring Trevi Therapeutics options at the current volatility level of 1.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

Open Interest Against 2026-04-17 Trevi Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Trevi Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Trevi Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Trevi Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Trevi Therapeutics' open interest, investors have to compare it to Trevi Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Trevi Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Trevi. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Trevi Therapeutics Additional Predictive Modules

Most predictive techniques to examine Trevi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Trevi using various technical indicators. When you analyze Trevi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Trevi Therapeutics has current Accumulation Distribution of 0.0677. The accumulation distribution (A/D) indicator shows the degree to which Trevi Therapeutics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Trevi Therapeutics to determine if accumulation or reduction is taking place in the market. This value is adjusted by Trevi Therapeutics trading volume to give more weight to distributions with higher volume over lower volume.
Check Trevi Therapeutics VolatilityBacktest Trevi TherapeuticsInformation Ratio  

Trevi Therapeutics Trading Date Momentum

On February 08 2026 Trevi Therapeutics was traded for  11.46  at the closing time. The top price for the day was 11.81  and the lowest listed price was  11.01 . There was no trading activity during the period 0.0. Lack of trading volume on February 8, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 2.36% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Trevi Therapeutics to competition

Other Forecasting Options for Trevi Therapeutics

For every potential investor in Trevi, whether a beginner or expert, Trevi Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Trevi Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Trevi. Basic forecasting techniques help filter out the noise by identifying Trevi Therapeutics' price trends.

Trevi Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trevi Therapeutics stock to make a market-neutral strategy. Peer analysis of Trevi Therapeutics could also be used in its relative valuation, which is a method of valuing Trevi Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Trevi Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Trevi Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trevi Therapeutics shares will generate the highest return on investment. By undertsting and applying Trevi Therapeutics stock market strength indicators, traders can identify Trevi Therapeutics entry and exit signals to maximize returns.

Trevi Therapeutics Risk Indicators

The analysis of Trevi Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Trevi Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting trevi stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for Trevi Therapeutics

The number of cover stories for Trevi Therapeutics depends on current market conditions and Trevi Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Trevi Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Trevi Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Trevi Therapeutics Short Properties

Trevi Therapeutics' future price predictability will typically decrease when Trevi Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Trevi Therapeutics often depends not only on the future outlook of the potential Trevi Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Trevi Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding101 M
Cash And Short Term Investments107.6 M
When determining whether Trevi Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trevi Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trevi Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trevi Therapeutics Stock:
Check out Historical Fundamental Analysis of Trevi Therapeutics to cross-verify your projections.
For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is there potential for Pharmaceuticals market expansion? Will Trevi introduce new products? Factors like these will boost the valuation of Trevi Therapeutics. If investors know Trevi will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Trevi Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.37)
Return On Assets
(0.24)
Return On Equity
(0.37)
Understanding Trevi Therapeutics requires distinguishing between market price and book value, where the latter reflects Trevi's accounting equity. The concept of intrinsic value - what Trevi Therapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Trevi Therapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Trevi Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Trevi Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Trevi Therapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.